Company: NGVT
Filing Date: 2025-03-19
Form Type: PRER14A
Source: 0001308179-25-000166
Chunk: 8

Company: Ingevity Corp
Filing Date: 2025-03-19
Form: PRER14A
Chunk 8
---
 with the goal of developing a constructive dialogue focused on maximizing stockholder value. On December 6, 2024, Mr. Fisher provided Mr. Mather a copy of the requested questionnaire that is required to be submitted by all director candidates in connection with their nomination and directed Mr. Mather to the advance notice provisions contained within the Company’s Bylaws for additional requirements for Board nominations. On December 12, 2024, Mr. Fernandez-Moreno and Ms. Blackwell spoke to representatives from Vision One, including Mr. Mather, via teleconference regarding why they invested in the Company, their views about potential strategic alternatives for the Company’s businesses, and their perspectives about the Company’s current strategy and capital allocation. During this meeting, Mr. Fernandez-Moreno referred to his October 30 announcement and reiterated that the Company was actively progressing on various fronts and was already in the process of evaluating its portfolio, but that he was unable to share any non-public specifics. Further, Mr. Fernandez-Moreno assured the Vision One representatives that he would relay their thoughts to the entire Board. On December 16, 2024, the Board, including all members of the N&G Committee, had a regularly scheduled meeting during which they discussed Vision One’s letter and the subsequent conversation with Mr. Fernandez-Moreno and Ms. Blackwell. The Board also discussed its continued strategic review of the Company’s portfolio and corporate strategy. As part of the Company’s ongoing board refreshment process, on December 16, 2024, Ingevity announced the appointment of J. Kevin Willis to the Board, which was the culmination of a search process that first began in June 2024 and was conducted with the assistance of an independent search firm. Mr. Willis brings extensive experience as a CFO of a publicly traded, sustainability-focused specialty chemicals company with international reach, as well as integral skills in strategic planning and execution, including returns-driven capital allocation planning, operating efficiencies initiatives and business portfolio management. In appointing him, the Board expressed its confidence in Mr. Willis and emphasized the importance of adding a director whose profile and skillsets complement the existing Board and the needs of the Company, enhancing the Board’s composition for the next stage of the Company’s growth. On January 16, 2025, Ingevity announced plans to explore strategic alternatives for most of the industrial specialties product line of its Performance Chemicals Segment and portions of its North Charleston refinery. In the press release announcing the initiation of this process, Mr.